(1) Department of Haematology/Oncology, The Queen Elizabeth Hospital, 5011 Woodville, South Australia, Australia;(2) Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital, 5011 Woodville, South Australia, Australia
Abstract:
Background
The EphB4 receptor tyrosine kinase has been reported as increased in tumours originating from several different tissues and its expression in a prostate cancer xenograft model has been reported.